Ftse Mib
34.309,99
-1,04%
DAX
18.405,64
-1,10%
S&P 500
5.291,34
0,15%
NASDAQ
16.857,05
0,17%
Bitcoin
70.560,75
2,55%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bioverativ Inc. (delisted) (BIVV) Bioverativ Inc. (delisted) (BIVV) Notizie

BIVV

Bioverativ Inc. (BIVV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIVV
DataOraFonteTitoloSimboloCompagnia
10/04/201817:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIVVBioverativ Inc. (delisted)
19/03/201821:37Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BIVVBioverativ Inc. (delisted)
08/03/201818:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIVVBioverativ Inc. (delisted)
08/03/201816:58Edgar (US Regulatory)(25-NSE)NASDAQ:BIVVBioverativ Inc. (delisted)
08/03/201815:34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BIVVBioverativ Inc. (delisted)
08/03/201815:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIVVBioverativ Inc. (delisted)
08/03/201815:10Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:BIVVBioverativ Inc. (delisted)
08/03/201812:12Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:BIVVBioverativ Inc. (delisted)
08/03/201812:11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:BIVVBioverativ Inc. (delisted)
06/03/201813:30Business WireBioverativ Announces First Patient Dosed in Phase 3 Study of BIVV009 for Treatment of Cold Agglutinin DiseaseNASDAQ:BIVVBioverativ Inc. (delisted)
03/03/201800:30PR Newswire (US)IPG Photonics Set to Join S&P 500; ALLETE and LendingTree to Join S&P MidCap 400; New York Mortgage Trust, Global Net Lease a...NASDAQ:BIVVBioverativ Inc. (delisted)
23/02/201812:44Dow Jones NewsSanofi Says U.S. Waiting Period for Bioverativ Has ExpiredNASDAQ:BIVVBioverativ Inc. (delisted)
14/02/201814:00Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIVVBioverativ Inc. (delisted)
14/02/201813:00Business WireHaemophilia Publishes a Retrospective Analysis Investigating the Use of ELOCTATE® for Immune Tolerance Induction in People w...NASDAQ:BIVVBioverativ Inc. (delisted)
13/02/201822:15Business WireBioverativ Reports Fourth Quarter and Full Year 2017 PerformanceNASDAQ:BIVVBioverativ Inc. (delisted)
08/02/201812:07Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:BIVVBioverativ Inc. (delisted)
07/02/201823:20Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:BIVVBioverativ Inc. (delisted)
24/01/201818:39PR Newswire (US)WeissLaw LLP Investigates Bioverativ Inc. AcquisitionNASDAQ:BIVVBioverativ Inc. (delisted)
23/01/201823:41Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:BIVVBioverativ Inc. (delisted)
23/01/201809:02Dow Jones NewsDrug Firms Bet Billions on Biotech -- WSJNASDAQ:BIVVBioverativ Inc. (delisted)
23/01/201802:00Dow Jones NewsBig Drugmakers Pay Big Prices for Promising Biotechs -- UpdateNASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201820:13Dow Jones NewsBig Drugmakers Pay Big Prices for Promising BiotechsNASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201818:19PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Bioverativ Inc.NASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201814:49PR Newswire (US)Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc.NASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201813:01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201809:02Dow Jones NewsSanofi Nears Deal for Bioverativ -- WSJNASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201808:01Dow Jones NewsSanofi to Acquire Bioverativ for $11.6 BillionNASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201803:07Dow Jones NewsSanofi Nears Deal to Buy Hemophilia Drugmaker Bioverativ for More Than $11.5 Billion -- UpdateNASDAQ:BIVVBioverativ Inc. (delisted)
22/01/201802:49Dow Jones NewsSanofi Nears Deal to Buy Hemophilia Drugmaker Bioverativ for More Than $11.5 BillionNASDAQ:BIVVBioverativ Inc. (delisted)
16/01/201822:15Business WireBioverativ to Report Fourth Quarter and Year-End 2017 Financial Results on February 13, 2018NASDAQ:BIVVBioverativ Inc. (delisted)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIVV

La tua Cronologia

BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
SRG
Snam
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network